Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,798,538 papers from all fields of science
Search
Sign In
Create Free Account
Poly(ADP-Ribose) Polymerase Inhibitors [MoA]
Known as:
Poly ADP Ribose Polymerase Inhibitors
, Poly (ADP-Ribose) Polymerase Inhibitors
, Poly ADP-Ribose Polymerase Inhibitors
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Poly(ADP-Ribose) Polymerase Inhibitor [EPC]
Poly(ADP-ribose) Polymerase Inhibitors
olaparib
olaparib 50 MG Oral Capsule
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Abstract P6-08-21: Prevalence of HER2 positivity in germlineBRCA 1/2-associated breast cancers (gBRCA1/2-BC)
Kristen D Whitaker
,
E. Obeid
,
L. Goldstein
,
M. Daly
2020
Corpus ID: 216392268
Purpose: To define the prevalence of HER2 positive breast cancer (HER2+ BC) in women with gBRCA1/2-BC and to determine whether…
Expand
2019
2019
Abstract 3501: Entinostat enhances the efficacy of olaparib in preclinical models of ovarian cancer
Vijayalaxmi G Gupta
,
Yoskaly Lazo Fernandez
,
+5 authors
D. Khabele
Molecular and Cellular Biology / Genetics
2019
Corpus ID: 198380648
Introduction: Ovarian cancer is a rare but often fatal disease and a leading cause of gynecologic cancer death, in the United…
Expand
Highly Cited
2018
Highly Cited
2018
The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer.
Andrew J. Wilson
,
M. Stubbs
,
Phillip C. C. Liu
,
B. Ruggeri
,
D. Khabele
Gynecologic Oncology
2018
Corpus ID: 4965414
Review
2018
Review
2018
Principles of clinical management of ovarian cancer.
T. Gorodnova
,
A. Sokolenko
,
E. Kuligina
,
I. Berlev
,
E. Imyanitov
Chinese Clinical Oncology
2018
Corpus ID: 54557613
Epithelial ovarian cancer (EOC) is a common malignant disease, which remains asymptomatic for a prolonged period of time and is…
Expand
2018
2018
Altering Nitrogen Heterocycles of AZD2461 Affords High Affinity Poly(ADP-ribose) Polymerase-1 Inhibitors with Decreased P-Glycoprotein Interactions
S. Reilly
,
Laura N. Puentes
,
Chia-Ju Hsieh
,
Mehran Makvandi
,
R. Mach
ACS Omega
2018
Corpus ID: 52158592
Poly(ADP-ribose) polymerase inhibitors (PARPi) are targeted therapeutics with enhanced selectivity and cytotoxicity in BRCA1/2…
Expand
Highly Cited
2016
Highly Cited
2016
Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition
J. Murai
,
Ying Feng
,
+4 authors
Y. Pommier
OncoTarget
2016
Corpus ID: 3596319
Poly(ADP-ribose) polymerase inhibitors (PARPIs) kill cancer cells by trapping PARP1 and PARP2. Talazoparib, the most potent PARPI…
Expand
Highly Cited
1996
Highly Cited
1996
Lactate stimulation of macrophage-derived angiogenic activity is associated with inhibition of Poly(ADP-ribose) synthesis.
D. Zabel
,
Feng Jj
,
H. Scheuenstuhl
,
T. Hunt
,
Hussain Mz
Laboratory investigation; a journal of technical…
1996
Corpus ID: 20424554
Injury and inflammation lead to hypoxia and elevated lactate in wounds. This redox environment establishes cells in a reparative…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE